NYSEAMERICAN:APHB

Ampliphi Biosciences Stock Forecast, Price & News

$4.29
-0.30 (-6.54 %)
(As of 06/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.21
$4.79
50-Day Range N/A
52-Week Range
$0.15
$1.37
Volume37,547 shs
Average Volume842,200 shs
Market Capitalization$143.58 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive APHB News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampliphi Biosciences and its competitors with MarketBeat's FREE daily newsletter.


Ampliphi Biosciences logo

About Ampliphi Biosciences

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. It holds collaborative research and development agreements with the United States Army Medical Research and Materiel Command for the development of bacteriophage therapeutics to treat S. aureus, E. coli, and P. aeruginosa infections; and Walter Reed Army Institute of Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.56 out of 5 stars

Medical Sector

1506th out of 2,100 stocks

Biotechnology Industry

25th out of 88 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Ampliphi Biosciences (NYSEAMERICAN:APHB) Frequently Asked Questions

What stocks does MarketBeat like better than Ampliphi Biosciences?

Wall Street analysts have given Ampliphi Biosciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Ampliphi Biosciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Ampliphi Biosciences' earnings last quarter?

Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) released its quarterly earnings data on Monday, March, 25th. The biotechnology company reported ($0.15) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.08) by $0.07.
View Ampliphi Biosciences' earnings history
.

Who are Ampliphi Biosciences' key executives?

Ampliphi Biosciences' management team includes the following people:
  • Dr. Paul C. Grint, CEO & Director (Age 61)
  • Mr. Steven R. Martin, Sr. VP & CFO (Age 58)
  • Mr. Michael Scott Salka, Consultant (Age 57)

Who are some of Ampliphi Biosciences' key competitors?

What other stocks do shareholders of Ampliphi Biosciences own?

What is Ampliphi Biosciences' stock symbol?

Ampliphi Biosciences trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "APHB."

How do I buy shares of Ampliphi Biosciences?

Shares of APHB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ampliphi Biosciences' stock price today?

One share of APHB stock can currently be purchased for approximately $4.29.

How much money does Ampliphi Biosciences make?

Ampliphi Biosciences has a market capitalization of $143.58 million.

How many employees does Ampliphi Biosciences have?

Ampliphi Biosciences employs 30 workers across the globe.

What is Ampliphi Biosciences' official website?

The official website for Ampliphi Biosciences is www.ampliphibio.com.

Where are Ampliphi Biosciences' headquarters?

Ampliphi Biosciences is headquartered at 3579 Valley Centre Drive, SAN DIEGO, CA 92130, United States.

How can I contact Ampliphi Biosciences?

Ampliphi Biosciences' mailing address is 3579 Valley Centre Drive, SAN DIEGO, CA 92130, United States. The biotechnology company can be reached via phone at +1-804-8272524.


This page was last updated on 6/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.